"Thiazines/metabolism"[MAJR] - Search Results

Year	Number of Results
1965	8
1966	8
1967	18
1968	21
1969	16
1970	24
1971	33
1972	35
1973	45
1974	65
1975	57
1976	68
1977	80
1978	94
1979	118
1980	157
1981	199
1982	140
1983	175
1984	170
1985	158
1986	161
1987	154
1988	196
1989	168
1990	141
1991	132
1992	140
1993	122
1994	89
1995	121
1996	98
1997	84
1998	76
1999	79
2000	81
2001	107
2002	71
2003	90
2004	89
2005	77
2006	57
2007	108
2008	76
2009	79
2010	99
2011	94
2012	93
2013	117
2014	109
2015	126
2016	144
2017	121
2018	121
2019	121
2020	78
2021	55
2022	32
2023	32
2024	34

1

Structure-Based Analysis of Cefaclor Pharmacokinetic Diversity According to Human Peptide Transporter-1 Genetic Polymorphism.

Jang JH, Jeong SH. Jang JH, et al. Int J Mol Sci. 2024 Jun 22;25(13):6880. doi: 10.3390/ijms25136880. Int J Mol Sci. 2024. PMID: 38999989 Free PMC article.

2

Cucurbit[7]uril-based host-guest complexes for improving bioavailability and reducing side effects of piroxicam.

Wang Y, Yang X, Luo J, Yi S, Guo T, Liao Y, Yu C, Zhang X. Wang Y, et al. Int J Pharm. 2024 Jul 20;660:124351. doi: 10.1016/j.ijpharm.2024.124351. Epub 2024 Jun 17. Int J Pharm. 2024. PMID: 38897491

3

Ceftobiprole quantification in human serum by HPLC-UV to implement routine TDM in clinical practice.

Boccardi D, Marini V, Baiardi G, Cameran Caviglia M, Sacco F, Piras F, Del Puente F, Boni S, Pontali E, Mattioli F. Boccardi D, et al. Clin Chim Acta. 2024 Jul 15;561:119806. doi: 10.1016/j.cca.2024.119806. Epub 2024 Jun 7. Clin Chim Acta. 2024. PMID: 38852792 Free article.

4

Quantification of cefuroxime and flucloxacillin in synovial tissue and bone using ultra-performance convergence chromatography-tandem mass spectrometry.

Bahmany S, Holst A, Hoogendoorn MH, Oosterhoff M, van Oldenrijk J, Bos PK, Veltman ES, Koch BCP. Bahmany S, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2024 Jul 1;1241:124169. doi: 10.1016/j.jchromb.2024.124169. Epub 2024 May 26. J Chromatogr B Analyt Technol Biomed Life Sci. 2024. PMID: 38815354 Free article.

5

Evaluation of the ARK Diagnostics immunoassay for qualitative detection of xylazine in urine.

Kyle PB, Mattiello CJ, Hua A, Toohey JM, Korn WR, Saldana-Reed A, Stickle DF. Kyle PB, et al. J Anal Toxicol. 2024 Jul 13;48(6):468-471. doi: 10.1093/jat/bkae043. J Anal Toxicol. 2024. PMID: 38804901

6

Plasma and tissue concentrations of 2 g prophylactic cefazolin prior to lower extremity surgery.

Eelsing R, Penning D, Vos-van der Meer M, Hodiamont CJ, Mathôt RAA, Schepers T. Eelsing R, et al. Antimicrob Agents Chemother. 2024 Jul 9;68(7):e0049424. doi: 10.1128/aac.00494-24. Epub 2024 May 21. Antimicrob Agents Chemother. 2024. PMID: 38771030 Free PMC article. Clinical Trial.

7

Population pharmacokinetics and pharmacodynamic target attainment analysis of cefazolin using total and unbound serum concentration in patients with prostatectomy or nephrectomy.

Komatsu T, Kawai Y, Takayama Y, Akamada Y, Kusume E, Ikeda M, Tsumura H, Ishii D, Iwamura M, Okamoto H, Hanaki H, Otori K. Komatsu T, et al. Antimicrob Agents Chemother. 2024 Jul 9;68(7):e0026724. doi: 10.1128/aac.00267-24. Epub 2024 May 21. Antimicrob Agents Chemother. 2024. PMID: 38771029

8

Desosomes and desimicelles - a novel vesicular and micellar system for enhanced oral delivery of poorly soluble drug: Optimization of in vitro characteristics and in vivo performance.

Said AR, Asaad GF, Shabana ME, Sayed AS, Elfeky DH, Mohamed Ali H, Adel Abdelfattah A, M El-Husseiny H, El-Dakroury WA. Said AR, et al. Eur J Pharm Biopharm. 2024 Jul;200:114324. doi: 10.1016/j.ejpb.2024.114324. Epub 2024 May 15. Eur J Pharm Biopharm. 2024. PMID: 38759898

9

Statistical design and optimization of nano-transfersomes based chitosan gel for transdermal delivery of cefepime.

Mirza R, Shah KU, Khan AU, Fawad M, Rehman AU, Ahmed N, Nawaz A, Shah SU, Alasmari AF, Alharbi M, Alasmari F, Hafeez Z, Haq SU. Mirza R, et al. Drug Dev Ind Pharm. 2024 Jun;50(6):511-523. doi: 10.1080/03639045.2024.2353098. Epub 2024 May 21. Drug Dev Ind Pharm. 2024. PMID: 38718267

10

In Vitro In Vivo Extrapolation and Bioequivalence Prediction for Immediate-Release Capsules of Cefadroxil Based on a Physiologically-Based Pharmacokinetic ACAT Model.

Rahim N, Naqvi SBS. Rahim N, et al. AAPS PharmSciTech. 2024 May 7;25(5):100. doi: 10.1208/s12249-024-02811-z. AAPS PharmSciTech. 2024. PMID: 38714602

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

5,366 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

5,366 results

Results by year